Viking Therapeutics (VKTX) Assets (2014 - 2026)
Viking Therapeutics (VKTX) reported Assets of $521.9 million for Q2 2026, down 37.0% from $827.85 million a year earlier and down 14.2% from the prior quarter.
Powered by 
Analysis
Viking Therapeutics (VKTX) Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Viking Therapeutics posted Assets of $715.73 million, down 21.2% from FY2024.
- Assets has a five-year compound annual growth rate of 22.8% (FY2020 to FY2025).
- By year, Assets came in at $908.32 million in FY2024 (+146.5%), $368.49 million in FY2023 (+118.7%), $168.53 million in FY2022 (-20.0%) and $210.66 million in FY2021 (-17.9%).
- The Q2 2026 figure ranks as the lowest quarterly Assets since Q4 2023.
- Year over year, Assets has now declined in each of the last six quarters, with growth averaging 19.9% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q1 2024 (growth of 541.2%); the low point was Q2 2026 (a decline of 37.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $608.24 million (Q1 2026), $715.73 million (Q4 2025) and $739.42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.15 Bn | 1,101.73 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 616.41 Bn | 534.94 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 501.01 Bn | 474.12 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 367.15 Bn | 321.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.00 Bn | 261.99 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.56 Bn | 235.25 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 235.40 Bn | 190.80 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 190.38 Bn | 164.57 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 169.76 Bn | 116.40 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Viking Therapeutics | 3.10 Bn | 578.92 Mn | - | 521.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 521.90 Mn |
| Mar 31, 2026 | 608.24 Mn |
| Dec 31, 2025 | 715.73 Mn |
| Sep 30, 2025 | 739.42 Mn |
| Jun 30, 2025 | 827.85 Mn |
| Mar 31, 2025 | 866.99 Mn |
| Dec 31, 2024 | 908.32 Mn |
| Sep 30, 2024 | 937.89 Mn |
| Jun 30, 2024 | 946.84 Mn |
| Mar 31, 2024 | 967.52 Mn |
| Dec 31, 2023 | 368.49 Mn |
| Sep 30, 2023 | 382.66 Mn |
| Jun 30, 2023 | 400.69 Mn |
| Mar 31, 2023 | 150.90 Mn |
| Dec 31, 2022 | 168.53 Mn |
| Sep 30, 2022 | 166.68 Mn |
| Jun 30, 2022 | 181.51 Mn |
| Mar 31, 2022 | 195.03 Mn |
| Dec 31, 2021 | 210.66 Mn |
| Sep 30, 2021 | 224.47 Mn |
API Access
Viking Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();